A Study to Evaluate the Safety of mRNA-0184 in Participants With Heart Failure

Status:
Recruiting

Trial end date:
2024-05-07

Target enrollment:

Participant gender:

The primary objective of this study is to evaluate the safety and tolerability of single and multiple doses at escalating dose levels of mRNA-0184.

Phase 1

ModernaTX, Inc.